45
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effectiveness of TruScreen for Detecting CIN2+ in Women with ThinPrep Cytologic Test Results Indicating Atypical Squamous Cells of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesions

ORCID Icon, , , , , , & ORCID Icon show all
Pages 2493-2504 | Received 05 Apr 2023, Accepted 16 Nov 2023, Published online: 06 Dec 2023

References

  • International Agency for Research on Cancer . Global Cancer Observatory: Cancer Today. https://gco.iarc.fr/today/
  • Xia C , HuS, XuXet al. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health4(9), e462–e472 (2019).
  • Sawaya GF , Smith-McCuneK, KuppermannM. Cervical cancer screening: more choices in 2019. JAMA321(20), 2018–2019 (2019).
  • Cheung LC , EgemenD, ChenXet al. 2019 ASCCP Risk-Based Management Consensus Guidelines: methods for risk estimation, recommended management, and validation. J. Low. Genit. Tract Dis.24(2), 90–101 (2020).
  • Cox JT , CastlePE, BehrensCMet al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am. J. Obstet. Gynecol.208(3), 184.e1–184.e11 (2013).
  • Cuzick J , ClavelC, PetryKUet al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer119(5), 1095–1101 (2006).
  • Arbyn M , AntoineJ, ValerianovaZet al. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania. Tumori96(4), 517–523 (2010).
  • Sawaya G , LamarR, PerkinsR. Managing minimally abnormal cervical cancer screening test results. JAMA324(15), 1557–1558 (2020).
  • Kaul V , EnslinS, GrossSA. History of artificial intelligence in medicine. Gastrointest. Endosc.92(4), 807–812 (2020).
  • Drukker L , NobleJA, PapageorghiouAT. Introduction to artificial intelligence in ultrasound imaging in obstetrics and gynecology. Ultrasound Obstet. Gynecol.56(4), 498–505 (2020).
  • Singer A , CopplesonM, CanfellKet al. A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation. Int. J. Gynecol. Cancer13(6), 804–811 (2003).
  • Wei Y , WangW, ChengMet al. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening. Eur. J. Obstet. Gynecol. Reprod. Biol.266, 182–186 (2021).
  • Wang Z , KangY, YuFet al. TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the COVID-19 pandemic. Future Oncol17(10), 1197–1207 (2021).
  • Barrow A , WuS. Impedance measurements for cervical cancer diagnosis. Gynecol. Oncol.107, S40–S43 (2007).
  • Liu AH , WalkerJ, GageJCet al. Diagnosis of cervical precancers by endocervical curettage at colposcopy of women with abnormal cervical cytology. Obstet. Gynecol.130(6), 1218–1225 (2017).
  • Walker P , DexeusS, DePalo Get al. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet. Gynecol.101(1), 175–177 (2003).
  • Jordão P , RussomanoF, GerbauldG, AndradeC, OsorioC. Accuracy of endocervical cytological tests in diagnosing preinvasive lesions of the cervical canal in patients with type 3 transformation zone: a retrospective observational study. Sao Paulo Med. J.138(1), 47–53 (2020).
  • The People’s Bank of China . One-year time deposit interest rate of China. www.pbc.gov.cn/zhengcehuobisi/125207/125213/125440/125838/125888/2809409/index.html
  • Bao H , ZhangL, WangLet al. Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset. Cancer Med.7(5), 2089–2100 (2018).
  • Chen W , ZhengR, BaadePDet al. Cancer statistics in China, 2015. CA Cancer J. Clin.66(2), 115–132 (2016).
  • Tao X , AustinR, KongLet al. Nationwide survey of cervical cytology laboratory practices in China. J. Am. Soc. Cytopathol.8(5), 250–257 (2019).
  • Chatzistamatiou K , MoysiadisT, MoschakiV, PantelerisN, AgorastosT. Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening. Gynecol. Oncol.142(1), 120–127 (2016).
  • Ozgu E , YildizY, OzguBS, OzM, DanismanN, GungorT. Efficacy of a real time optoelectronic device (TruScreen) in detecting cervical intraepithelial pathologies: a prospective observational study. J. Turk. Ger. Gynecol. Assoc.16(1), 41–44 (2015).
  • Kim C , VantureS, ChoM, KlapperichC, WangC, HuangF. Awareness, interest, and preferences of primary care providers in using point-of-care cancer screening technology. PLOS ONE11(1), e0145215 (2016).
  • Yang H , ZhangX, HaoZ. The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore)97(29), e11439 (2018).
  • Suchonska B , Gajzlerska-MajewskaW, WielgosM. Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations. PLOS ONE16(2), e0247702 (2021).
  • Ren H , JiaM, ZhaoS, LiH, FanS. Factors correlated with the accuracy of colposcopy-directed biopsy: a systematic review and meta-analysis. J. Investig. Surg.35(2), 284–292 (2022).
  • Moy LM , ZhaoFH, LiLYet al. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral. Int. J. Cancer127(3), 646–656 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.